Microsatellite instability: from the implementation of the detection to a prognostic and predictive role in cancers

M Amato, R Franco, G Facchini, R Addeo… - International journal of …, 2022 - mdpi.com
Microsatellite instability (MSI) has been identified in several tumors arising from either
germline or somatic aberration. The presence of MSI in cancer predicts the sensitivity to …

MLH1 Methylation Testing as an Integral Component of Universal Endometrial Cancer Screening—A Critical Appraisal

A Plotkin, E Olkhov-Mitsel, S Nofech-Mozes - Cancers, 2023 - mdpi.com
Simple Summary Often in endometrial cancer (EC), the mismatch repair (MMR) system,
which helps fix DNA mistakes, goes haywire because of MLH1 promoter hypermethylation …

Case report: Exploring Lynch Syndrome through genomic analysis in a mestizo Ecuadorian patient and his brother

P Guevara-Ramírez, VA Ruiz-Pozo… - Frontiers in …, 2024 - frontiersin.org
Lynch Syndrome (LS) is a hereditary disorder characterized by genetic mutations in DNA
mismatch repair genes, affecting approximately 0.35% of the population. LS primarily …

Immunohistochemical Markers in Endometrial Cancer: Latest Updates

V Mais, M Peiretti - Cancers, 2023 - mdpi.com
Ten years ago, The Cancer Genome Atlas (TGCA) Research Network classified endometrial
cancer into four molecular categories with prognostic significance, suggesting sensitivity to …

[HTML][HTML] Correlation between immunohistochemical staining and clinicopathological findings in endometrial carcinoma

SN Saharti, FJ Altaf - Saudi Medical Journal, 2024 - ncbi.nlm.nih.gov
Objectives: To analyze the immunohistochemical staining pattern of mismatch repair (MMR)
proteins and p53 in endometrial carcinoma cases, including different subtypes and stages …

[PDF][PDF] The Role of Epigenetics in Hereditary Colorectal Cancer Tumorigenesis: Validation of Genome

T Puustinen - Nature Reviews Clinical Oncology, 2022 - helda.helsinki.fi
Colorectal cancer (CRC) poses a considerable global health challenge, with high mortality
rates despite advancements in cancer research. Approximately one in ten CRC cases have …